Apheris
Life sciences data networks for AI
Published Oct 15, 2026
| Starting Price | Enterprise — marketplace placeholders indicate large annual license values and add-ons, typically negotiated | Public and community-discussed constructs exist; pricing is enterprise-oriented and community posts discuss per-collaborator models (plus compute/storage) | Not transparently priced publicly; typically enterprise or partnership-based |
| Best For | Federated ML/analytics across organizations where raw data remains in custodian environments; life sciences data networks | Secure multi-party analytics collaboration for organizations already using Databricks; clean-room style workflows | Life sciences organizations seeking federated learning plus platform/services and research partnerships |
| Key Strength | Focus on computational governance and a data-custodian controlled gateway architecture; emphasis on life sciences networks | Integration with Databricks ecosystem, Delta Sharing, and managed execution models | Domain specialization in life sciences and established research partnerships |
| Key Weakness | High cost and adoption overhead; limited public review volume; permissioning friction reported | Potential cost model complexity; requires alignment with Databricks platform; clean-room model may not suit all federated training needs | May be more platform-and-services oriented than a standalone governance gateway product |
—
Differentiation
Pricing comparison
Adoption trends / market signals